C62.00
Malignant neoplasm of unspecified undescended testis
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of an unspecified undescended testis refers to a type of testicular cancer that develops in an undescended testicle whose exact location has not been specified. An undescended testis, also known as cryptorchidism, is a condition where one or both of the testicles fail to move into the scrotum before birth. If a testicle remains undescended and develops cancer, it is classified under this specific ICD-10 code. Recognizing the nature of this condition is essential for understanding its implications, diagnosis, and management options.
Causes & Symptoms
Clinical Causes: Genetic predisposition plays a significant role, with family history increasing risk. Hormonal factors during fetal development may impact testicular descent and cancer risk. Environmental exposures such as endocrine-disrupting chemicals or toxins have been studied as potential contributors. History of cryptorchidism, especially if untreated, is a major risk factor for developing testicular cancer. Certain chromosomal abnormalities like Klinefelter syndrome can increase susceptibility.
Key Symptoms: A painless swelling or lump in the groin or scrotal area. A sensation of heaviness or discomfort in the scrotum or groin. A feeling of ache or pain that may radiate to the lower abdomen or back. Reduced fertility, especially if one or both testes are undescended. In advanced cases, symptoms related to metastasis such as cough, shortness of breath, or swelling in the limbs may occur.
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm of an undescended testis involves a combination of physical examination, imaging studies, and laboratory tests. Key steps include: - Physical Exam: Evaluation of the groin, abdomen, and scrotal area to identify any lumps or abnormalities. - Ultrasound: The primary imaging modality used to locate the undescended testis and assess for masses. - Serum Tumor Markers: Blood tests measuring alpha-fetoprotein (AFP), beta-human chorionic gonadotropin (β-hCG), and lactate dehydrogenase (LDH), which can aid in diagnosis and monitoring. - Additional Imaging: CT scans or MRI may be used to evaluate regional lymph nodes or detect metastasis. Early detection is crucial for effective management and improved prognosis. Because the condition involves an undescended testis, examination may be challenging compared to normally descended testes.
Treatment Protocols: Management of testicular cancer originating from an undescended testis typically involves a multidisciplinary approach: - Surgery: Orchiectomy, the removal of the affected testis, is usually the first step. - Radiotherapy: May be used in certain cases, especially if the tumor type is sensitive. - Chemotherapy: Often required if the cancer has metastasized or based on tumor staging. - Surveillance: Regular follow-up including imaging and serum markers to monitor for recurrence. Treatment plans are tailored based on the tumor type, stage, and patient health factors. Early intervention improves the chances of successful treatment.
Clinical Advice & FAQs
Billing Guidance
Is C62.00 a billable ICD-10 code?
Yes, C62.00 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C62.00?
Clinical documentation must specify the nature of Malignant neoplasm of unspecified undescended testis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference